Dow Down1.50% Nasdaq Down2.41%

Myriad Genetics, Inc. (MYGN)

-NasdaqGS
29.12 Down 0.88(2.93%) Jun 27, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2015Jun 30, 2014Jun 30, 2013
Total Revenue 723,100   778,200   613,200  
Cost of Revenue147,400  109,200  79,700  
Gross Profit 575,700   669,000   533,500  
Operating Expenses
Research Development75,500  67,500  53,700  
Selling General and Administrative366,000  327,100  251,800  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 134,200   274,400   228,000  
Income from Continuing Operations
Total Other Income/Expenses Net700  3,400  5,300  
Earnings Before Interest And Taxes134,900  277,800  233,300  
Interest Expense -   -   -  
Income Before Tax134,900  277,800  233,300  
Income Tax Expense54,700  101,600  86,100  
Minority Interest -   -   -  
Net Income From Continuing Ops80,200  176,200  147,200  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 80,200   176,200   147,200  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 80,200   176,200   147,200  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.